Skrining i procjena umora povezanog s rakom: Smjernica za kliničku praksu za pružaoce zdravstvenih usluga.
Physical therapy
Sažetak istraživanja
Umor povezan s rakom (CRF) je najčešća nuspojava liječenja raka. Preporučuje se redovni nadzor, ali nekoliko smjernica kliničke prakse transparentno procjenjuju pristrasnost studije, kvalitet i kliničku korisnost u izvođenju preporuka za metode skrininga i procjene.
Svrha ove smjernice za kliničku praksu (CPG) je da pruži preporuke za skrining i procjenu CRF-a za zdravstvene profesije koje liječe osobe sa rakom. Slijedeći najbolje prakse za razvoj CPG-a koristeći Izjavu o procjeni smjernica za istraživanje i evaluaciju (AGREE) i Smjernice Instituta za hitnu pomoć (ECRI) Trust Scorecard, ovaj CPG je uključivao sistematsko pretraživanje literature, procjenu kvaliteta uključenih dokaza i doprinos zainteresovanih strana iz različitih oblasti zdravstvene zaštite kako bi se dobio konačni CPG. Pregledano je deset skrining i 15 alata za procjenu podržanih sa 114 članaka. Jedan ekran (European Organization for Research and Treatment of Cancer-Quality Life Questionnaire-30 Core Questionnaire) i 3 procjene (Piper Fatigue Scale-Revided, Function Assessment of Chronic Illness Therapy-Fatigue, and Patient Reported Outcome Question Ishode Information System) (PROM. koristi se u kliničkoj praksi"), a 1 pregled i 5 procjena dobili su preporuku B ("može se koristiti u kliničkoj praksi"). Pružaoci zdravstvenih usluga imaju izbor u određivanju odgovarajućih alata za skrining i procjenu koji će se koristiti u cijelom kontinuumu porodične skrbi. Veliki broj dostupnih alata za skrining ili procjenu CRF-a može rezultirati nedostatkom sveobuhvatnih istraživačkih dokaza, ostavljajući praznine u korpusu dokaza za alate za mjerenje. Potrebno je više istraživanja o osjetljivosti ovih alata kako bi se usvojila njihova upotreba kao mjere ishoda. Impact Pružaoci zdravstvenih usluga bi trebali pregledati i procijeniti CRF koristeći jedan od alata preporučenih u ovom CPG-u.
Prikaži originalni naslov i sažetak na engleskom
Screening and Assessment of Cancer-Related Fatigue: A Clinical Practice Guideline for Health Care Providers.
Cancer-related fatigue (CRF) is the most common side effect of cancer treatment. Regular surveillance is recommended, but few clinical practice guidelines transparently assess study bias, quality, and clinical utility in deriving recommendations of screening and assessment methods. The purpose of this clinical practice guideline (CPG) is to provide recommendations for the screening and assessment of CRF for health care professions treating individuals with cancer. Following best practices for development of a CPG using the Appraisal of Guidelines for Research and Evaluation (AGREE) Statement and Emergency Care Research Institute (ECRI) Guidelines Trust Scorecard, this CPG included a systematic search of the literature, quality assessment of included evidence, and stakeholder input from diverse health care fields to derive the final CPG. Ten screening and 15 assessment tools supported by 114 articles were reviewed. One screen (European Organisation for Research and Treatment of Cancer-Quality of Life Questionnaire-30 Core Questionnaire) and 3 assessments (Piper Fatigue Scale-Revised, Functional Assessment of Chronic Illness Therapy-Fatigue, and Patient Reported Outcome Measurement Information System [PROMIS] Fatigue-SF) received an A recommendation ("should be used in clinical practice"), and 1 screen and 5 assessments received a B recommendation ("may be used in clinical practice"). Health care providers have choice in determining appropriate screening and assessment tools to be used across the survivorship care continuum. The large number of tools available to screen for or assess CRF may result in a lack of comprehensive research evidence, leaving gaps in the body of evidence for measurement tools. More research into the responsiveness of these tools is needed in order to adopt their use as outcome measures. Impact Health care providers should screen for and assess CRF using one of the tools recommended by this CPG.
Izvorni podaci
- DOI
- 10.1093/ptj/pzac120
- PMID
- 36179114
- PMCID
- PMC9525018
- Provjereno
- 2026-07-26
Naslov i sažetak prevedeni su automatski i prijevod može sadržavati netačnosti ili neprecizne stručne izraze. Za sve detalje, citiranje i medicinsko tumačenje pregledajte originalnu englesku verziju članka. Ne donosite zdravstvene odluke samo na osnovu ovog prijevoda.
Pregledaj originalni članak na engleskom